Search Ontology:
ChEBI
panobinostat
- Term ID
- CHEBI:85990
- Synonyms
-
- (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide
- LBH 589
- LBH589
- panobinostat
- Definition
- A hydroxamic acid obtained by formal condensation of the carboxy group of (2E)-3-[4-({[2-(2-methylindol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enoic acid with the amino group of hydroxylamine. A histone deacetylase inhibitor used (as its lactate salt) in combination with bortezomib and dexamethasone for the treatment of multiple myeloma.
- References
-
- CAS:404950-80-7
- Drug_Central:4682
- KEGG:D10319
- PMID:25305451
- PMID:25377157
- PMID:25410127
- PMID:25458954
- PMID:25572329
- PMID:25608569
- PMID:25612941
- PMID:25628765
- PMID:25710456
- PMID:25802326
- PMID:25837990
- PMID:25870990
- PMID:25904215
- PMID:25939707
- PMID:25944617
- PMID:26000292
- PMID:26030093
- PMID:26051506
- Reaxys:12257756
- Wikipedia:Panobinostat
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from panobinostat
Phenotype where environments contain panobinostat
Phenotype modified by environments containing panobinostat
Human Disease Model